Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Allen

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Neurology|July 17, 2015
CIDP diagnostic pitfalls and perception of treatment benefitJeffrey A Allen, Richard A Lewis
Seminars in Neurology|October 28, 2015
Acquired Immunologic NeuropathiesJeffrey A Allen, Gareth J Parry
Muscle & Nerve|February 7, 2018
ReplyJeffrey A Allen, Richard A Lewis
Expert Review of Neurotherapeutics|June 16, 2021
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practiceJeffrey A Allen, Filip Eftimov, Luis Querol
Brain and Behavior|March 16, 2018
Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Kenneth C Gorson, Deborah Gelinas
Archives of Neurology|October 13, 2006
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancerJeffrey A Allen, Ashish Adlakha, Peter R Bergethon
Muscle & Nerve|July 26, 2020
Fatigue in chronic inflammatory demyelinating polyneuropathyKarissa L Gable, Hrayr Attarian, Jeffrey A Allen
Muscle & Nerve|April 17, 2019
Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosisAri Breiner, Pierre R Bourque, Jeffrey A Allen
Muscle & Nerve|August 21, 2023
Anti-myelin-associated glycoprotein neuropathy: Where do we stand?Amro Maher Stino, Bakri Elsheikh, Jeffrey A Allen
Muscle & Nerve|November 18, 2009
Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosisJeffrey A Allen, Stephanie Scala, H Royden Jones
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Neurology|July 17, 2015
CIDP diagnostic pitfalls and perception of treatment benefitJeffrey A Allen, Richard A Lewis
Seminars in Neurology|October 28, 2015
Acquired Immunologic NeuropathiesJeffrey A Allen, Gareth J Parry
Muscle & Nerve|February 7, 2018
ReplyJeffrey A Allen, Richard A Lewis
Expert Review of Neurotherapeutics|June 16, 2021
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practiceJeffrey A Allen, Filip Eftimov, Luis Querol
Brain and Behavior|March 16, 2018
Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Kenneth C Gorson, Deborah Gelinas
Archives of Neurology|October 13, 2006
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancerJeffrey A Allen, Ashish Adlakha, Peter R Bergethon
Muscle & Nerve|July 26, 2020
Fatigue in chronic inflammatory demyelinating polyneuropathyKarissa L Gable, Hrayr Attarian, Jeffrey A Allen
Muscle & Nerve|April 17, 2019
Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosisAri Breiner, Pierre R Bourque, Jeffrey A Allen
Muscle & Nerve|August 21, 2023
Anti-myelin-associated glycoprotein neuropathy: Where do we stand?Amro Maher Stino, Bakri Elsheikh, Jeffrey A Allen
Muscle & Nerve|November 18, 2009
Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosisJeffrey A Allen, Stephanie Scala, H Royden Jones
Pageof 6